Abel Hall LLC’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Abel Hall LLC's AMGN Position: Q2 2026 in Review
Abel Hall LLC reduced its Amgen (AMGN) stake by 35% in Q2 2026, selling an estimated $295K and leaving 1,570 shares worth $569K. The position accounts for 0.1% of the portfolio, ranked #199.
Abel Hall LLC first reported a position in AMGN in Q1 2025 and has held it in 5 quarters since. The position peaked at $855K in Q1 2026. 1,278 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Abel Hall LLC held 1,570 shares of Amgen worth $569K as of Q2 2026.
- Abel Hall LLC sold 861 Amgen shares in Q2 2026, an estimated $295K.
- Amgen made up 0.1% of Abel Hall LLC's portfolio in Q2 2026, its #199 holding.
- Abel Hall LLC first reported a position in Amgen in Q1 2025 and has held it in 5 quarters since.
- Abel Hall LLC's Amgen position peaked at $855K in Q1 2026.
- 1,278 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.